As a research center embedded within Kaiser Permanente’s large and dynamic health care system, our investigators have a unique opportunity to apply scientific expertise to real-world clinical problems, translate findings into practice, and share what we learn with the broader community.
Dr. Stanley Xu is a senior research scientist biostatistician in the Division of Biostatistics Research in the Department of Research & Evaluation. He has served as principal investigator, co-investigator, and lead biostatistician on randomized trials and observational studies funded by the National Institutes of Health, Agency for Healthcare Research and Quality, Centers for Disease Control and Prevention, and the U.S. Food and Drug Administration. He has published novel statistical methods ...
Over the years, clinical trials have led to amazing advances in treatment—even cures—for devastating illnesses. William Towner, MD, FACP, FIDSA, regional physician director for clinical trials, describes how trials at Kaiser Permanente contribute to the development of more effective and safer treatments for diseases such as HIV, hepatitis C, cancer, and more. (2:15)
*Fourth in a series highlighting research nurses during Nurses Week 2025* Ruchy Maini, LVN, is a research nurse working at the Antelope Valley Medical Offices in Lancaster. She has worked with patients in clinical trials with the Department of Research & Evaluation since 2019. While she has worked in home health and skilled nursing facility ...
*Third in a series highlighting research nurses during Nurses Week 2025* Noli Raz, RN, works at the Kaiser Permanente Irvine Medical Center with the CCTAP (Cancer Clinical Trials Access Program) team. He began his health care career more than 30 years ago as a phlebotomist at the Kaiser Permanente Anaheim Medical Center, where he worked ...
*Second in a series celebrating research nurses during Nurses Week 2025* Kari Kayser, RN, works at the Kaiser Permanente South Bay Medical Center with the CCTAP (Cancer Clinical Trials Access Program) team. Her choice to dress as a nurse on career day as a kindergartener showed an early passion for a vocation that she now ...
*First in a series celebrating research nurses during Nurses Week 2025* Michelle Jurado, MSN, RN, PHN, didn’t intend to become a nurse. She was good with numbers, so she went into finance in the aerospace industry. It was going really well. But then one night at a party, her mom missed a step, fell, and ...
Jaejin An, PhD, was awarded the Early Career Investigator of the Year award at this year’s Health Care Systems Research Network conference held this month in St. Louis, Missouri. Dr. An is a pharmacoepidemiologist and cardiovascular outcomes researcher for the Kaiser Permanente Southern California Department of Research & Evaluation whose work focuses on disease management, ...
The latest IMPACT newsletter, which focuses on research from Kaiser Permanente Southern California, is now available! It features 11 stories on our groundbreaking research, links to over a dozen media stories, and a Q&A with a health economics investigator.
Investigators with the Division of Epidemiologic Research apply rigorous research methods to address important health questions that have the potential to change clinical practice and health care delivery. The division’s research portfolio spans the care continuum, from etiology and prevention to survivorship and quality of life.
Division investigators have expertise in traditional epidemiologic studies, post-marketing safety and effectiveness studies, and outcomes research. Current research areas include cancer, cardiovascular disease, COVID-19, diabetes, infectious disease, molecular epidemiology, orthopedics and bone health, perinatal health, pharmacoepidemiology, and vaccines.